<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02087163</url>
  </required_header>
  <id_info>
    <org_study_id>CSP-700007-00</org_study_id>
    <nct_id>NCT02087163</nct_id>
  </id_info>
  <brief_title>The Use of Clear Aligners With Movement Enhancement Techniques</brief_title>
  <official_title>The Use of Clear Aligners With Movement Enhancement Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Align Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Align Technology, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use clear aligners to measure tooth movement and length of
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Orthodontic tooth movement is the result of a force applied to the crown of a tooth and the
      biological remodeling of the gum and bony tissues.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">April 2019</completion_date>
  <primary_completion_date type="Actual">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tooth Movement Change</measure>
    <time_frame>Baseline and end of treatment, an average of 78 weeks</time_frame>
    <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Tooth movement change will be measured as the number of millimeters of tooth movement per aligner.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Treatment Change</measure>
    <time_frame>Baseline and end of treatment, an average of 78 weeks</time_frame>
    <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Length of treatment change will be measured as the number of weeks of movement per aligner.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Malocclusion</condition>
  <arm_group>
    <arm_group_label>Movement Enhancement Technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Movement Enhancement Technique Clear Aligner</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Movement Enhancement Technique</intervention_name>
    <description>Conventional Orthodontic treatment</description>
    <arm_group_label>Movement Enhancement Technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clear Aligner</intervention_name>
    <description>Orthodontic treatment with Clear Aligner</description>
    <arm_group_label>Movement Enhancement Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Require Orthodontic Treatment

          -  Have a permanent dentition

          -  No craniofacial anomaly present

          -  No past and present signs and symptoms of periodontal disease

          -  No significant medical history or medication that would adversely affect the
             development or structure of the teeth and jaws and any subsequent tooth movement

          -  No previous orthodontic or orthopaedic relapse

          -  No history of trauma, bruxism or parafunction

          -  16- 46 years old, inclusive

          -  No skeletal jaw discrepancy

          -  Angle Class I or Class II molar and canine relationship

          -  Crowding of at least 4mm per arch

          -  No osteoporosis drugs

        Exclusion Criteria:

          -  Subjects who do not fulfill all inclusion criteria requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chenin</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Kottemann</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_official>
    <last_name>Mariani</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Align Technology, Inc.</name>
      <address>
        <city>San Jose</city>
        <state>California</state>
        <zip>95131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 28, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2014</study_first_posted>
  <results_first_submitted>January 8, 2019</results_first_submitted>
  <results_first_submitted_qc>April 3, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 24, 2019</results_first_posted>
  <last_update_submitted>January 17, 2020</last_update_submitted>
  <last_update_submitted_qc>January 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malocclusion</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT02087163/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Movement Enhancement Technique</title>
          <description>Movement Enhancement Technique Clear Aligner
Movement Enhancement Technique: Conventional Orthodontic treatment
Clear Aligner: Orthodontic treatment with Clear Aligner</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Movement Enhancement Technique</title>
          <description>Movement Enhancement Technique Clear Aligner
Movement Enhancement Technique: Conventional Orthodontic treatment
Clear Aligner: Orthodontic treatment with Clear Aligner</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="90"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="90"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Tooth Movement Change</title>
        <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Tooth movement change will be measured as the number of millimeters of tooth movement per aligner.</description>
        <time_frame>Baseline and end of treatment, an average of 78 weeks</time_frame>
        <population>all completed subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Movement Enhancement Technique</title>
            <description>Movement Enhancement Technique Clear Aligner
Movement Enhancement Technique: Conventional Orthodontic treatment
Clear Aligner: Orthodontic treatment with Clear Aligner</description>
          </group>
        </group_list>
        <measure>
          <title>Tooth Movement Change</title>
          <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Tooth movement change will be measured as the number of millimeters of tooth movement per aligner.</description>
          <population>all completed subjects</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.363" lower_limit="-0.22" upper_limit="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Treatment Change</title>
        <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Length of treatment change will be measured as the number of weeks of movement per aligner.</description>
        <time_frame>Baseline and end of treatment, an average of 78 weeks</time_frame>
        <population>all completed subjects</population>
        <group_list>
          <group group_id="O1">
            <title>Movement Enhancement Technique</title>
            <description>Movement Enhancement Technique Clear Aligner
Movement Enhancement Technique: Conventional Orthodontic treatment
Clear Aligner: Orthodontic treatment with Clear Aligner</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Treatment Change</title>
          <description>Participants will be followed for the duration of orthodontic treatment, an expected average of 78 weeks. Length of treatment change will be measured as the number of weeks of movement per aligner.</description>
          <population>all completed subjects</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="342" lower_limit="-37.08" upper_limit="441.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>baseline until end of treatment, an average of 78 weeks</time_frame>
      <desc>An adverse event (AE) is any unwanted dental occurrence in a clinical investigation subject whether or not the AE is suspected of having a causal relationship with study treatment. Pre-existing events, which increase in frequency or severity or change in nature during or as a consequence of use of an appliance clinical trials, will also be considered as adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Movement Enhancement Technique</title>
          <description>Movement Enhancement Technique Clear Aligner
Movement Enhancement Technique: Conventional Orthodontic treatment
Clear Aligner: Orthodontic treatment with Clear Aligner</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="90"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="90"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="90"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Allison Mossing</name_or_title>
      <organization>Align Technology</organization>
      <phone>4084701056</phone>
      <email>amossing@aligntech.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

